Search

Search Constraints

You searched for: Author/Creator Olsen, Inge Christoffer

Search Results

1. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. (January 2022)

2. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Issue 12 (16th August 2017)

3. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes. Issue 10 (22nd June 2018)

4. Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial. Issue 2 (16th November 2018)

5. Early food intervention and skin emollients to prevent food allergy in young children (PreventADALL): a factorial, multicentre, cluster-randomised trial. Issue 10344 (25th June 2022)

6. First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach. Issue 8 (17th June 2015)

7. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. (September 2022)

8. Joint tenderness and ultrasound inflammation in DMARD-naïve patients with early rheumatoid arthritis. Issue 11 (3rd June 2021)

9. Neutrophil count predicts clinical outcome in hospitalized COVID‐19 patients: Results from the NOR‐Solidarity trial. (3rd October 2021)

10. Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria. Issue 2 (19th April 2016)